Joint Serum Tumor Markers Serve as survival predictive model of Erlotinib in the treatment of recurrent Non-small Cell Lung Cancer

by Lan SHAO, Wei HONG, Lei ZHENG, Chunxiao HE, Beibei ZHANG, Fajun XIE, Zhengbo SONG, Guangyuan LOU, Yiping ZHANG
Published 2014-05-01

Analysis of the Efficacy and Survival of Third-line Treatment 
in Advanced Non-small Cell Lung Cancer

by Lan SHAO, Zhengbo SONG, Lin HU, Fajun XIE, Guangyuan LOU, Wei HONG, Cuiping GU, Dan HONG, Baochai LIN, Yiping ZHANG
Published 2012-06-01

Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma

by Hongyang Lu, Shifeng Yang, Huineng Zhu, Xiaoling Tong, Fajun Xie, Jing Qin, Na Han, Xue Wu, Yun Fan, Yang W. Shao, Weimin Mao
Published 2018-03-01